Join the club for FREE to access the whole archive and other member benefits.

Blake Byers

Co-founder of NewLimit & investor in tech and biotech companies

Blake Byers is a Co-founder of NewLimit. He was a General Partner at Google Ventures where he led investments in tech and biotech companies. Over a decade, Blake led early investments in tech companies including Robinhood, Gusto, Dapper,, and IonQ, and biotech companies including Denali, Forty Seven, Magenta, Arcus, Armo, Grail, Freenome, and many others. Blake previously incubated PACT Pharma where he was founding president and now serves as Chairman of the board.

Blake received a PhD and MS in bioengineering from Stanford University and holds a BS in biomedical engineering and BS in economics from Duke University.

Visit website:



See also: Company NewLimit - Company focused on human health and Rejuvenation

Details last updated 19-Dec-2021

Blake Byers News

TechCrunch interviews founders of NewLimit after it received another $40m of funding

TechCrunch - 16-May-2023

Reprogramming the epigenetics of a cell could reverse a significant amount of the functional decline that we see with age


NewLimit, a new biotech launches to slowdown or reverse ageing

NewLimit - 12-Dec-2021

Aims to extend healthspan and cure ageing with affordable epigenetic therapies